跳到主要导航
跳到搜索
跳到主要内容
北京理工大学 首页
English
中文
首页
师资队伍
研究单位
科研成果
奖项
按专业知识、名称或附属进行搜索
查看 Scopus 资料
梁 建华
化学与化工学院
h-index
436
引用
12
H-指数
根据储存在 Pure 的刊物以及来自 Scopus 的引用文献数量计算
1999
2024
每年的科研成果
概览
指纹图谱
合作网络
科研成果
(55)
相似学者
(1)
指纹图谱
深入其中 Jianhua Liang 为活跃的研究主题。这些主题标签来自此人的成果。它们共同形成唯一的指纹。
分类
加权
按字母排序
Pharmacology, Toxicology and Pharmaceutical Science
Erythromycin
100%
Oxime
87%
Macrolide
67%
Clarithromycin
55%
Structure Activity Relationship
51%
Antibacterial Activity
48%
Clarithromycin Derivative
47%
Ketolide
40%
Ribosome RNA
29%
Propenyl
29%
Epoxide Hydrolase
29%
Hydrolase Inhibitor
29%
Streptococcus Pneumoniae
28%
Azithromycin
26%
Infectious Agent
25%
Quinolone
23%
Quinolone Derivative
20%
Effusion
20%
Staphylococcal Pneumonia
19%
DNA Topoisomerase
19%
Antidepressant
18%
Peptide Nucleic Acid
14%
Reverse Phase High Performance Liquid Chromatography
14%
Cethromycin
14%
Experimental Neoplasm
14%
Acetal
14%
RNA Directed RNA Polymerase
14%
Pterostilbene
14%
Nucleic Acid Base
14%
Major Depression
14%
Hydrolase Inhibitor
14%
Sucrose Synthase
14%
Blood Extract
14%
RNA Directed RNA Polymerase Inhibitor
14%
Dragon Blood
14%
Carveol
14%
Mycobacterium Tuberculosis
14%
Meticillin
14%
Propane
14%
Drug Development
14%
DNA Topoisomerase (ATP Hydrolysing)
14%
Anti-Inflammatory Drug
14%
Glycyrrhetinic Acid Derivative
14%
Analgesic Agent
14%
Alzheimer's Disease
14%
Telithromycin
14%
Streptococcus pyogenes
13%
Natural Product
12%
Staphylococcus Aureus
12%
Oxime Derivative
10%
Chemistry
Oxime
94%
Erythromycin A
82%
Crystal Structure
69%
Clarithromycin
69%
Methylation
62%
Macrolide Antibiotic Agent
41%
Ketolide Antibiotic Agent
40%
Erythromycin
37%
Single Crystalline Solid
25%
Space Group
23%
Ribosomal RNA
20%
Regioselectivity
19%
Antibacterial
19%
Structure-Activity Relationship
19%
Quinolone
18%
Telithromycin
17%
1H-Imidazole
14%
Etherification
14%
One Pot Reaction
14%
Antiinflammatory
14%
Crystal Morphology
14%
Monoterpene
14%
Carveol
14%
Desilylation
14%
Tetragonal Space Group
9%
E Isomer
9%
Sodium Salt
9%
Imidazole
9%
Hydroxyl
8%
Monoclinic Space Group
8%
Acetonitrile
8%
Erythromycin Derivative
7%
Hydroxyl Group
7%
Solvent Mixture
7%
Methanol
7%
Sodium Borohydride
7%
Hexamethyldisilazane
7%
Protective
7%
Deetherification
7%
Beckmann Rearrangement
7%
Cladinose
7%
Antibiotic Resistance
5%